Carregant...
Clinical Evaluation of Adriamycin, a New Antitumour Antibiotic
Adriamycin, a new antitumour antibiotic of the anthracycline group with a structural formula very similar to daunorubicin, has proved to have potent tumour-growth-inhibiting properties, and to be particularly effective in childhood malignancies. Though adriamycin produces a higher percentage of side...
Guardat en:
Autors principals: | , , , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
1969
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1984262/ https://ncbi.nlm.nih.gov/pubmed/5257148 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|